Depomed Reports Third Quarter 2016 Financial Results

Go back to Depomed Reports Third Quarter 2016 Financial Results

Cantor Fitzgerald Downgrades DepoMed Inc (DEPO) to Hold

November 8, 2016 7:41 AM EST

Cantor Fitzgerald downgraded DepoMed Inc (NASDAQ: DEPO) from Buy to Hold with a price target of $23.00 (from $25.00).

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $22.89 yesterday.

... More